Patrick Yéni - Concepedia

Author

Patrick Yéni

Also Known As

Alena Ivanova, Clotet, Bonaventura, Donna M. Jacobsen, Eron, Joseph, Isaacs, Robin D., Katlama, Christine, Montaner, Julio S.G., Patrick G Yeni, Patrick G. Yeni, Patrick Yeni

119

Publications

15.5K

Citations

H-Index

Concepts

All Affiliations

Hôpital Bichat-Claude-Bernard Inserm Université Claude Bernard Lyon 1 Assistance Publique – Hôpitaux de Paris Sorbonne Université

About

Patrick Yéni is an author at Hôpital Bichat-Claude-Bernard specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	2.6K
2	Health Sciences	3	3	264
3	Natural Sciences	1	1	45
4	Public Health	1	1	19
5	Biochemistry	1	1	45

Patrick Yéni

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Treatment for Adult HIV Infection Scott M. Hammer, Michael S. Saag, Mauro Schechter, JAMA	2006	1K
Antiretroviral Treatment of Adult HIV Infection Scott M. Hammer, Joseph J. Eron, Peter Reiss, JAMA	2008	1K
Treatment for Adult HIV Infection Patrick Yéni, Scott M. Hammer, Martin Hirsch, JAMA	2004	736
Antiretroviral Treatment of Adult HIV Infection Melanie Thompson, Judith A. Aberg, Pedro Cahn, JAMA	2010	724
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection Roy T. Steigbigel, David A. Cooper, Princy Kumar, New England Journal of Medicine	2008	683
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel Martin S. Hirsch, Huldrych F. Günthard, Jonathan Schapiro, Clinical Infectious Diseases Sexual HealthTreatment And PreventionHuman RetrovirusAntiviral TherapyResistance Mutation (Virology)	2008	573
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection David A. Cooper, Roy T. Steigbigel, José M. Gatell, New England Journal of Medicine	2008	505
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era Olivier Sitbon, Caroline Lascoux‐Combe, Jean‐François Delfraissy, American Journal of Respiratory and Critical Care Medicine	2007	451
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial Joseph J. Eron, Patrick Yéni, Joseph Gathe, The Lancet Klean StudyTreatment And PreventionHiv InfectionClinical TrialsAntiviral Drug Development	2006	341

Page 1